Chronic Kidney Disease Progression and Transition Probabilities in a Large Preventive Cohort in Colombia.

IF 1.7 Q3 UROLOGY & NEPHROLOGY
International Journal of Nephrology Pub Date : 2021-03-31 eCollection Date: 2021-01-01 DOI:10.1155/2021/8866446
Jasmin I Vesga, Edilberto Cepeda, Campo E Pardo, Sergio Paez, Ricardo Sanchez, Rafael M Sanabria
{"title":"Chronic Kidney Disease Progression and Transition Probabilities in a Large Preventive Cohort in Colombia.","authors":"Jasmin I Vesga, Edilberto Cepeda, Campo E Pardo, Sergio Paez, Ricardo Sanchez, Rafael M Sanabria","doi":"10.1155/2021/8866446","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Variability in chronic kidney disease (CKD) progression is a well-known phenomenon that underlines the importance of characterizing the said outcome in specific populations. Our objectives were to evaluate changes in the estimated glomerular filtration rate (eGFR) over time and determine the frequency of dialysis admission and factors associated with this outcome, to estimate the rate of program's loss-to-follow-up and the probability of transition between CKD stages over time.</p><p><strong>Methods: </strong>The study type was an observational analytic retrospective cohort in patients treated in a CKD prevention program in Bogota, Colombia, between January 1, 2009, and December 31, 2013, with follow-up until December 31, 2018. Adult participants of 18 years of age or older with diagnosed CKD stages G3 or G4 were enrolled into a prevention program. For each patient, the rate of progression of CKD in ml/min/1.73 m<sup>2</sup>/year was estimated using the ordinary least-squares method. Dialysis initiation and program's loss-to-follow-up rates were calculated. Heat maps were used to present probabilities of transitioning between various CKD stages over time. Survival model with competing risks was used to evaluate factors associated with dialysis initiation.</p><p><strong>Results: </strong>A total of 2752 patients met inclusion criteria and contributed with 14133 patient-years of follow-up and 200 dialysis initiation events, which represents a rate of 1.4 events per 100 patient-years (95% CI 1.2 to 1.6). The median change of the eGFR for the entire cohort was -0.47 ml/min/1.73 m<sup>2</sup> per year, and in the diabetic population, it was -1.55 ml/min/1.73 m<sup>2</sup> per year. The program's loss-to-follow-up rate was 2.6 events per 100 patient-years (95% CI 2.3 to 2.9). Probabilities of CKD stage transitions are presented in heat maps. Female sex, older age, baseline eGFR, and serum albumin were associated with lower risk of dialysis initiation while CKD etiology diabetes, cardiovascular disease history, systolic blood pressure, blood urea nitrogen, and LDL cholesterol were associated with a higher likelihood of dialysis initiation.</p><p><strong>Conclusions: </strong>A CKD secondary prevention program's key indicator is reported here, such as dialysis initiation, progression rate, and program drop-out; CKD progression appears to be correlated with diabetic status and timing of referral into the preventive program.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2021 ","pages":"8866446"},"PeriodicalIF":1.7000,"publicationDate":"2021-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032521/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2021/8866446","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Variability in chronic kidney disease (CKD) progression is a well-known phenomenon that underlines the importance of characterizing the said outcome in specific populations. Our objectives were to evaluate changes in the estimated glomerular filtration rate (eGFR) over time and determine the frequency of dialysis admission and factors associated with this outcome, to estimate the rate of program's loss-to-follow-up and the probability of transition between CKD stages over time.

Methods: The study type was an observational analytic retrospective cohort in patients treated in a CKD prevention program in Bogota, Colombia, between January 1, 2009, and December 31, 2013, with follow-up until December 31, 2018. Adult participants of 18 years of age or older with diagnosed CKD stages G3 or G4 were enrolled into a prevention program. For each patient, the rate of progression of CKD in ml/min/1.73 m2/year was estimated using the ordinary least-squares method. Dialysis initiation and program's loss-to-follow-up rates were calculated. Heat maps were used to present probabilities of transitioning between various CKD stages over time. Survival model with competing risks was used to evaluate factors associated with dialysis initiation.

Results: A total of 2752 patients met inclusion criteria and contributed with 14133 patient-years of follow-up and 200 dialysis initiation events, which represents a rate of 1.4 events per 100 patient-years (95% CI 1.2 to 1.6). The median change of the eGFR for the entire cohort was -0.47 ml/min/1.73 m2 per year, and in the diabetic population, it was -1.55 ml/min/1.73 m2 per year. The program's loss-to-follow-up rate was 2.6 events per 100 patient-years (95% CI 2.3 to 2.9). Probabilities of CKD stage transitions are presented in heat maps. Female sex, older age, baseline eGFR, and serum albumin were associated with lower risk of dialysis initiation while CKD etiology diabetes, cardiovascular disease history, systolic blood pressure, blood urea nitrogen, and LDL cholesterol were associated with a higher likelihood of dialysis initiation.

Conclusions: A CKD secondary prevention program's key indicator is reported here, such as dialysis initiation, progression rate, and program drop-out; CKD progression appears to be correlated with diabetic status and timing of referral into the preventive program.

Abstract Image

Abstract Image

Abstract Image

哥伦比亚大型预防性队列中的慢性肾病进展和转变概率。
背景:众所周知,慢性肾脏病(CKD)发展过程中存在差异,这凸显了描述特定人群中上述结果的重要性。我们的目标是评估估计肾小球滤过率(eGFR)随时间推移的变化,确定接受透析的频率以及与这一结果相关的因素,估算随访项目的流失率以及随时间推移在 CKD 阶段之间转换的概率:研究类型为观察性分析回顾性队列,研究对象为2009年1月1日至2013年12月31日期间在哥伦比亚波哥大接受CKD预防项目治疗的患者,随访至2018年12月31日。年龄在 18 岁或 18 岁以上、确诊为 CKD G3 或 G4 期的成年参与者被纳入预防计划。采用普通最小二乘法估算了每位患者的 CKD 进展率,单位为毫升/分钟/1.73 平方米/年。计算了透析启动率和项目的随访丧失率。热图用于显示随时间在不同 CKD 阶段之间转换的概率。采用竞争风险生存模型评估与开始透析相关的因素:共有 2752 名患者符合纳入标准,随访了 14133 个患者年,发生了 200 起透析启动事件,即每 100 个患者年发生 1.4 起透析启动事件(95% CI 1.2 至 1.6)。整个群体的 eGFR 变化中位数为每年-0.47 毫升/分钟/1.73 平方米,糖尿病患者的 eGFR 变化中位数为每年-1.55 毫升/分钟/1.73 平方米。该计划的随访损失率为每 100 患者年 2.6 例(95% CI 2.3 至 2.9)。CKD 阶段转换概率在热图中显示。女性性别、老年、基线 eGFR 和血清白蛋白与较低的透析启动风险相关,而 CKD 病因糖尿病、心血管疾病史、收缩压、血尿素氮和低密度脂蛋白胆固醇与较高的透析启动可能性相关:结论:本文报告了一项慢性肾脏病二级预防计划的关键指标,如透析启动、进展率和计划退出;慢性肾脏病的进展似乎与糖尿病状态和转入预防计划的时间有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Nephrology
International Journal of Nephrology UROLOGY & NEPHROLOGY-
CiteScore
3.40
自引率
4.80%
发文量
44
审稿时长
17 weeks
期刊介绍: International Journal of Nephrology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies focusing on the prevention, diagnosis, and management of kidney diseases and associated disorders. The journal welcomes submissions related to cell biology, developmental biology, genetics, immunology, pathology, pathophysiology of renal disease and progression, clinical nephrology, dialysis, and transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信